Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG

---

Publications & Presentations

21. Zelnicek T D, Miller J L, Vijayarajah S, Johnson P N. A Case Series and Review of Literature Describing the Use of Midodrine for Vasopressor Effects in Infants With Congenital Heart Disease. Hospital Pharmacy. 2024; 59 : 544-551

22. Johnson P N, Parman A, Miller J L. Training the next generation of peer reviewers: Steps for guiding pharmacy learners through the peer review process. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2024; 81 : e137-e140

23. Casten M, Miller J L, Neely S, Harkin M, Johnson P N. Variability in opioid conversion calculators in critically ill children transitioned from fentanyl to hydromorphone. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2024; 81 : 153-158

24. Bradford C V, Parman A M, Johnson P N, Miller J L. Pharmacologic Management of Sialorrhea in Neonatal and Pediatric Patients. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2024; 29 : 6-21

25. Rathbun C, Lewis M M, Yuet W C, Woo S, Miller J L, Skrepnek G H. The Medication Possession Ratio as a Predictor of Longitudinal HIV-1 Viral Suppression. The Annals of pharmacotherapy. 2023; 57 : 1264-1272

Grants

1. Selenium Pharmacokinetics and Pharmacodynamics of Infants with Intestinal Failure a Prospective Cohort Study. Misc Non-Federal. Start Date: 2025. End Date: 2026.

2. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

3. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

5. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

Awards and Honors

1. Pediatric Pharmacy Association. Outstanding Original Research Award. Date: 2026.


2. University of Oklahoma College of Pharmacy Alumni Association. Ralph D. Bienfang Outstanding Practitioner Award. Date: 2025.


3. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2025.


4. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2024.


5. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2024.

Education

1. Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.


2. Degree: BS. Trevecca Nazarene University. Date: 2002.

Administrative Assignments

1. Role: Department Vice-Chair. Scope: Department. Date: 2021.
Read More